ESC 365 - What is the optimal treatment of asymptomatic patients with primary electrical syndromes?

ESC Premium Access

What is the optimal treatment of asymptomatic patients with primary electrical syndromes?

Session: Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects?

Topic: Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Speaker: Professor K. Haugaa (Stockholm, SE)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Professor Kristina Hermann Haugaa

Karolinska University Hospital, Stockholm (Sweden)

14 presentations

7 followers

4 more presentations in this session

Prophylactic ablation of preexcitation: when and for whom?

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Treatment of asymptomatic PVCs: when should it be attempted?

Speaker: Professor T. Reichlin (Bern, CH)

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? – discussion.

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects? - Chat Moderator.

Access the full session

Treatment of asymptomatic patients with arrhythmic substrates: do benefits outweigh side effects?

Speakers: Professor K. Haugaa, Professor J. Brugada Terradellas, Professor T. Reichlin

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

Related content

EHRA Premium Access

Hot topics in ventricular tachycardia.

5 April 2022

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

ESC Premium Access

Ventricular tachycardia storm in Lamin A/C Cardiomyopathy A combined epicardial-endocardial radiofrequency ablation.

27 August 2021

ESC 365 is supported by